Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Glucagon-like Peptide-1”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableLooking for participantsNCT03878706
What this trial is testing

The Cardiovascular Effect of GLP-1 Agonist, SGLT2 Inhibitor and Their Combination

Who this might be right for
Diabetes Mellitus, Type 2
University of Athens 240
Testing effectiveness (Phase 2)Study completedNCT06851858
What this trial is testing

Efficacy, Safety and Tolerability of AZD6234 in Participants Living With Overweight or Obesity With Type 2 Diabetes Who Are on a Stable Dose of GLP-1 Receptor Agonist

Who this might be right for
EndocrinologyDiabetes, Type IIObesity
AstraZeneca 69
Not applicableStudy completedNCT01666223
What this trial is testing

Effect of Bile Acids on GLP-1 Secretion

Who this might be right for
Type 2 DiabetesObesity
University Hospital, Gentofte, Copenhagen 20
Testing effectiveness (Phase 2)Study completedNCT05302596
What this trial is testing

Semaglutide Use in Elderly Obese Patients

Who this might be right for
ObesityAging
State University of New York at Buffalo 16
Not applicableStudy completedNCT01739283
What this trial is testing

GIP and GLP-1 in Type 1 Diabetes

Who this might be right for
Hypoglycemia
Mikkel Christensen 10
Not applicableStudy completedNCT00418288
What this trial is testing

The Effect of GLP-1 on Glucose Uptake in the Brain and Heart in Healthy Men During Hypoglycemia

Who this might be right for
Type 2 DiabetesStrokeMyocardial Infarction
University of Aarhus 10
Post-approval studies (Phase 4)Study completedNCT02276196
What this trial is testing

Effect of LIXIsenatide on the Renal System

Who this might be right for
Diabetic Kidney DiseaseDiabetic NephropathyDiabetes Mellitus+1 more
Amsterdam UMC, location VUmc 40
Testing effectiveness (Phase 2)Looking for participantsNCT07220473
What this trial is testing

Tirzepatide to Slow Biological Aging

Who this might be right for
AgingLONGEVITY 1
The University of Texas Medical Branch, Galveston 90
Post-approval studies (Phase 4)Not Yet RecruitingNCT07251556
What this trial is testing

GLP-1 Receptor Agonists in Non-diabetic Patients With Psoriatic Arthritis

Who this might be right for
Psoriasis Arthritis
Chinese University of Hong Kong 40
Not applicableNot Yet RecruitingNCT07797101
What this trial is testing

Body-weight Reduction Effect on Portal Hypertension in Compensated Cirrhosis

Who this might be right for
CirrhosisPortal HypertensionFatty Liver Disease+1 more
The Second Affiliated Hospital of Chongqing Medical University 50
Not applicableStudy completedNCT07475143
What this trial is testing

A Comparative Study Between Effect Of Mini-gastric Bypass and Single Anastmosis Sleeve Jujenal Bypass On Levels Of GLP-1, GIP, PYY, Insulin Resistance and Type II DM Resolution

Who this might be right for
Incretin Hormones Plasma LevelsGastric Bypass Surgery
Ain Shams University 40
Not applicableEnded earlyNCT00207389
What this trial is testing

Examine Changes in GIP Plasma Levels Following Gastric Bypass Surgery in Obese Patients

Who this might be right for
ObesityType 2 Diabetes MellitusInsulin Resistance
Boston Medical Center 5
Post-approval studies (Phase 4)Study completedNCT02170324
What this trial is testing

GLP-1 Agonism Stimulates Browning of Subcutaneous White Adipose Tissue in Obesity Men

Who this might be right for
Obesity
Xiang Guang-da 20
Early research (Phase 1)Study completedNCT04354090
What this trial is testing

Safety, Tolerability, Pharmacodynamics and Pharmacokinetics of JY09

Who this might be right for
Diabetes Mellitus, Type 2
Beijing Dongfang Biotech Co., Ltd. 41
Not applicableStudy completedNCT06722326
What this trial is testing

Hydrogen-rich Water and Appetite in Obesity

Who this might be right for
Obesity
University of Novi Sad, Faculty of Sport and Physical Education 36
Not applicableStudy completedNCT07563855
What this trial is testing

An Open Label Direct-to-Consumer Study Assessing the Impact of Health and Wellness Products on GI Health and Related Health Outcomes

Who this might be right for
HealthWellnessQuality of Life
PepsiCo Global R&D 133
Post-approval studies (Phase 4)Study completedNCT03331289
What this trial is testing

Can Exenatide Prevent Increase in EGP in Response to Dapagliflozin-induced Increase in Glucosuria

Who this might be right for
Diabetes Mellitus, Type 2
The University of Texas Health Science Center at San Antonio 107
Early research (Phase 1)Study completedNCT01664624
What this trial is testing

Roflumilast Plus Alogliptin Proof-of-Mechanism Study in Type2 Diabetes

Who this might be right for
Type 2 Diabetes
AstraZeneca 40
Early research (Phase 1)Study completedNCT02302976
What this trial is testing

GLP-1 Agonism for Blocking Cocaine Euphoria and Self-Administration

Who this might be right for
Cocaine Dependence
Yale University 13
Not applicableStudy completedNCT02994420
What this trial is testing

Endocrine and Neural Control of Eating in Women

Who this might be right for
Normal Body WeightObesity
University of Zurich 50
Next Page